
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_4{left:73px;top:59px;}
#t2_4{left:602px;top:59px;}
#t3_4{left:73px;top:517px;word-spacing:-3px;}
#t4_4{left:73px;top:536px;word-spacing:-2.5px;}
#t5_4{left:73px;top:554px;letter-spacing:-0.1px;word-spacing:2.7px;}
#t6_4{left:73px;top:572px;word-spacing:-0.4px;}
#t7_4{left:73px;top:591px;letter-spacing:-0.1px;}
#t8_4{left:92px;top:609px;letter-spacing:-0.1px;word-spacing:1.6px;}
#t9_4{left:73px;top:627px;word-spacing:2.5px;}
#ta_4{left:73px;top:646px;word-spacing:-0.4px;}
#tb_4{left:73px;top:664px;word-spacing:2.3px;}
#tc_4{left:73px;top:682px;word-spacing:1.9px;}
#td_4{left:73px;top:701px;word-spacing:5.4px;}
#te_4{left:73px;top:719px;letter-spacing:-0.1px;word-spacing:21.3px;}
#tf_4{left:73px;top:737px;word-spacing:-5.5px;}
#tg_4{left:73px;top:756px;word-spacing:8px;}
#th_4{left:73px;top:774px;word-spacing:-0.5px;}
#ti_4{left:73px;top:792px;word-spacing:0.2px;}
#tj_4{left:73px;top:811px;word-spacing:6.4px;}
#tk_4{left:73px;top:829px;word-spacing:0.2px;}
#tl_4{left:73px;top:847px;word-spacing:-0.7px;}
#tm_4{left:73px;top:866px;word-spacing:5.6px;}
#tn_4{left:73px;top:884px;word-spacing:8.3px;}
#to_4{left:73px;top:902px;word-spacing:1.4px;}
#tp_4{left:73px;top:921px;letter-spacing:-0.1px;word-spacing:-0.3px;}
#tq_4{left:73px;top:939px;word-spacing:1.2px;}
#tr_4{left:73px;top:957px;word-spacing:8.7px;}
#ts_4{left:73px;top:976px;word-spacing:3.9px;}
#tt_4{left:73px;top:994px;letter-spacing:-0.1px;word-spacing:0.1px;}
#tu_4{left:92px;top:1012px;letter-spacing:-1.2px;word-spacing:-0.7px;}
#tv_4{left:73px;top:1031px;letter-spacing:-1.2px;word-spacing:1.5px;}
#tw_4{left:73px;top:1049px;letter-spacing:-1.2px;word-spacing:-2.9px;}
#tx_4{left:73px;top:1067px;letter-spacing:-1.2px;word-spacing:6.8px;}
#ty_4{left:449px;top:517px;letter-spacing:-1.2px;word-spacing:32.6px;}
#tz_4{left:449px;top:536px;letter-spacing:-1.2px;word-spacing:4.5px;}
#t10_4{left:449px;top:554px;letter-spacing:-1.2px;word-spacing:-1.9px;}
#t11_4{left:449px;top:572px;letter-spacing:-1.3px;word-spacing:2.8px;}
#t12_4{left:449px;top:591px;letter-spacing:-1.2px;word-spacing:3.1px;}
#t13_4{left:449px;top:609px;letter-spacing:-0.5px;word-spacing:0.7px;}
#t14_4{left:449px;top:652px;}
#t15_4{left:449px;top:682px;word-spacing:19px;}
#t16_4{left:449px;top:701px;word-spacing:15.3px;}
#t17_4{left:449px;top:719px;letter-spacing:-0.1px;word-spacing:2.8px;}
#t18_4{left:449px;top:737px;word-spacing:10.4px;}
#t19_4{left:449px;top:756px;word-spacing:14.8px;}
#t1a_4{left:449px;top:774px;word-spacing:24.2px;}
#t1b_4{left:449px;top:792px;}
#t1c_4{left:468px;top:811px;letter-spacing:-0.9px;word-spacing:3.7px;}
#t1d_4{left:449px;top:829px;letter-spacing:-0.9px;word-spacing:16.5px;}
#t1e_4{left:449px;top:847px;letter-spacing:-0.9px;word-spacing:0.9px;}
#t1f_4{left:449px;top:866px;letter-spacing:-0.9px;word-spacing:3.8px;}
#t1g_4{left:449px;top:884px;letter-spacing:-1px;word-spacing:2.9px;}
#t1h_4{left:449px;top:902px;letter-spacing:-0.9px;word-spacing:-1.5px;}
#t1i_4{left:449px;top:921px;letter-spacing:-0.9px;word-spacing:-1.2px;}
#t1j_4{left:449px;top:939px;letter-spacing:-0.9px;word-spacing:4.5px;}
#t1k_4{left:449px;top:957px;letter-spacing:-0.9px;word-spacing:0.6px;}
#t1l_4{left:449px;top:976px;letter-spacing:-0.9px;word-spacing:9.3px;}
#t1m_4{left:449px;top:994px;letter-spacing:-0.9px;word-spacing:2.2px;}
#t1n_4{left:449px;top:1012px;letter-spacing:-0.9px;word-spacing:-2.7px;}
#t1o_4{left:449px;top:1031px;letter-spacing:-0.9px;word-spacing:-1.3px;}
#t1p_4{left:449px;top:1049px;letter-spacing:-0.9px;word-spacing:5.8px;}
#t1q_4{left:449px;top:1067px;letter-spacing:-0.2px;word-spacing:7px;}
#t1r_4{left:73px;top:101px;}
#t1s_4{left:132px;top:101px;}
#t1t_4{left:73px;top:129px;}
#t1u_4{left:305px;top:129px;}
#t1v_4{left:618px;top:129px;}
#t1w_4{left:73px;top:156px;}
#t1x_4{left:202px;top:156px;}
#t1y_4{left:500px;top:156px;}
#t1z_4{left:202px;top:174px;}
#t20_4{left:500px;top:174px;}
#t21_4{left:202px;top:192px;}
#t22_4{left:500px;top:192px;}
#t23_4{left:509px;top:208px;}
#t24_4{left:202px;top:225px;}
#t25_4{left:202px;top:243px;}
#t26_4{left:73px;top:260px;}
#t27_4{left:202px;top:260px;}
#t28_4{left:500px;top:260px;}
#t29_4{left:202px;top:278px;}
#t2a_4{left:500px;top:278px;}
#t2b_4{left:509px;top:294px;}
#t2c_4{left:202px;top:312px;}
#t2d_4{left:73px;top:329px;}
#t2e_4{left:202px;top:329px;}
#t2f_4{left:500px;top:329px;}
#t2g_4{left:509px;top:345px;}
#t2h_4{left:202px;top:363px;}
#t2i_4{left:500px;top:363px;}
#t2j_4{left:509px;top:379px;}
#t2k_4{left:202px;top:396px;}
#t2l_4{left:202px;top:414px;}
#t2m_4{left:211px;top:430px;}
#t2n_4{left:73px;top:460px;}
#t2o_4{left:96px;top:460px;}
#t2p_4{left:73px;top:475px;}
#t2q_4{left:428px;top:1172px;}
#t2r_4{left:366px;top:1172px;}
#t2s_4{left:304px;top:1172px;}

.s3_4{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: VHPCDS-TimesNewRomanPSMT4;
	color: rgb(35,31,32);
}

.s4_4{
	FONT-SIZE: 73.3px;
	FONT-FAMILY: VHPCDS-GillSansStd-Bold4;
	color: rgb(35,31,32);
}

.s6_4{
	FONT-SIZE: 55px;
	FONT-FAMILY: KGCOFO-GillSansStd4;
	color: rgb(35,31,32);
}

.s7_4{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: KGCOFO-GillSansStd-Italic4;
	color: rgb(35,31,32);
}

.s9_4{
	FONT-SIZE: 30.6px;
	FONT-FAMILY: Helvetica, Arial, sans-serif;
	color: rgb(0,0,0);
}

.s10_4{
	FONT-SIZE: 30.6px;
	FONT-FAMILY: Helvetica, Arial, sans-serif;
	color: rgb(0,0,255);
}

.s5_4{
	FONT-SIZE: 55px;
	FONT-FAMILY: VHPCDS-GillSansStd-Bold4;
	color: rgb(35,31,32);
}

.s8_4{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: KGCOFO-GillSansStd4;
	color: rgb(35,31,32);
}

.s1_4{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: KGCOFO-GillSansStd4;
	color: rgb(35,31,32);
}

.s2_4{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: KGCOFO-GillSansStd-Italic4;
	color: rgb(35,31,32);
}

#form4_1{	border-style:none;	z-index:2;	position: absolute;	left:364px;	top:1172px;	width:66px;	height:11px;	text-align:left;	background: transparent;	font:normal 7px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts4" type="text/css" >

@font-face {
	font-family: KGCOFO-GillSansStd-Italic4;
	src: url("4/fonts/KGCOFO-GillSansStd-Italic.woff") format("woff");
}

@font-face {
	font-family: KGCOFO-GillSansStd4;
	src: url("4/fonts/KGCOFO-GillSansStd.woff") format("woff");
}

@font-face {
	font-family: VHPCDS-TimesNewRomanPSMT4;
	src: url("4/fonts/VHPCDS-TimesNewRomanPSMT.woff") format("woff");
}

@font-face {
	font-family: VHPCDS-GillSansStd-Bold4;
	src: url("4/fonts/VHPCDS-GillSansStd-Bold.woff") format("woff");
}

</style>
<div id="t1_4" class="t s1_4">4 </div>
<div id="t2_4" class="t s2_4">American Journal of Menâ€™s Health</div>
<div id="t3_4" class="t s3_4">also been discussed in depth recently (reviewed in Kovac, </div>
<div id="t4_4" class="t s3_4">Pan, Lipshultz, &amp; Lamb, 2014). The relationship between </div>
<div id="t5_4" class="t s3_4">dietary adjuncts and prostate cancer, however, has never </div>
<div id="t6_4" class="t s3_4">been examined, so caution should be maintained in using </div>
<div id="t7_4" class="t s3_4">these adjuncts in men with prostate cancer.</div>
<div id="t8_4" class="t s3_4">With regard to clinical outcomes, patients undergoing </div>
<div id="t9_4" class="t s3_4">resistance training and supplementation with oral andro-</div>
<div id="ta_4" class="t s3_4">stenedione showed no increases in lean body mass, mean </div>
<div id="tb_4" class="t s3_4">cross-sectional area of type-two muscle fibers as well as </div>
<div id="tc_4" class="t s3_4">no decreases in fat mass versus placebo after 8 weeks of </div>
<div id="td_4" class="t s3_4">resistance training and 300 mg androstenedione supple-</div>
<div id="te_4" class="t s3_4">mentation (King et al., 1999). Additionally, patients </div>
<div id="tf_4" class="t s3_4">receiving androstenedione supplementation were reported </div>
<div id="tg_4" class="t s3_4">to have significantly lower HDL (high-density lipopro-</div>
<div id="th_4" class="t s3_4">tein) levels and significantly increased LDL (low-density </div>
<div id="ti_4" class="t s3_4">lipoprotein)/HDL and apolipoprotein A/apolipoprotein B </div>
<div id="tj_4" class="t s3_4">ratios versus placebo (Broeder et al., 2000; King et al., </div>
<div id="tk_4" class="t s3_4">1999). All of which pose an increased risk for cardiovas-</div>
<div id="tl_4" class="t s3_4">cular disease (Broeder et al., 2000; King et al., 1999). An </div>
<div id="tm_4" class="t s3_4">additional side effect of androstenedione was suggested </div>
<div id="tn_4" class="t s3_4">by a case report of a 29-year old male who developed </div>
<div id="to_4" class="t s3_4">impotence and oligospermia attributed to dietary supple-</div>
<div id="tp_4" class="t s3_4">mentation of androstenedione (Ritter, Cryar, &amp; Hermans, </div>
<div id="tq_4" class="t s3_4">2005). These findings were reversed 6 months following </div>
<div id="tr_4" class="t s3_4">cessation of the supplement and a subsequent 3-month </div>
<div id="ts_4" class="t s3_4">course of TST resolved his symptoms of low libido and </div>
<div id="tt_4" class="t s3_4">energy (Ritter et al., 2005).</div>
<div id="tu_4" class="t s3_4">While randomized trials are lacking, the accumulation of </div>
<div id="tv_4" class="t s3_4">available studies suggests that oral androstenedione supple-</div>
<div id="tw_4" class="t s3_4">mentation results in modest and temporary increase in serum </div>
<div id="tx_4" class="t s3_4">testosterone. Furthermore, it does so with very little to no </div>
<div id="ty_4" class="t s3_4">anabolic/myotrophic effects. The resultant detrimental </div>
<div id="tz_4" class="t s3_4">changes in blood lipid composition and potential increases </div>
<div id="t10_4" class="t s3_4">in cardiovascular disease risk make appropriate follow-up in </div>
<div id="t11_4" class="t s3_4">men using this adjunct very important (Table 1). Currently, </div>
<div id="t12_4" class="t s3_4">the preponderance of the evidence suggests its use to be of </div>
<div id="t13_4" class="t s3_4">minimal benefit in clinical application.</div>
<div id="t14_4" class="t s4_4">Androstenediol</div>
<div id="t15_4" class="t s3_4">Androstenediol is another endogenous androgen pro-</div>
<div id="t16_4" class="t s3_4">duced by modification of pregnenolone. It is derived </div>
<div id="t17_4" class="t s3_4">from DHEA and can be converted to testosterone by the </div>
<div id="t18_4" class="t s3_4">action of 3Î²-hydroxysteroid dehydrogenase (Figure 1). </div>
<div id="t19_4" class="t s3_4">Following this, testosterone can then be converted to </div>
<div id="t1a_4" class="t s3_4">estradiol via the action of aromatase as previously </div>
<div id="t1b_4" class="t s3_4">described (Figure 1).</div>
<div id="t1c_4" class="t s3_4">Oral supplementation of androstenediol has showed no </div>
<div id="t1d_4" class="t s3_4">statistically significant increases in area-under-the-curve </div>
<div id="t1e_4" class="t s3_4">concentrations of serum total and free testosterone 90 min-</div>
<div id="t1f_4" class="t s3_4">utes after administration (Earnest, Olson, Broeder, Breuel, </div>
<div id="t1g_4" class="t s3_4">&amp; Beckham, 2000). Interestingly, androstenediol produces </div>
<div id="t1h_4" class="t s3_4">a significant (103%-174%) increase in serum androstenedi-</div>
<div id="t1i_4" class="t s3_4">one levels after 90 minutes, indicating that there is likely an </div>
<div id="t1j_4" class="t s3_4">interconversion between androstenediol and androstenedi-</div>
<div id="t1k_4" class="t s3_4">one (Brown et al., 2001; Earnest et al., 2000). The increase </div>
<div id="t1l_4" class="t s3_4">in androstenedione levels and relative lack of significant </div>
<div id="t1m_4" class="t s3_4">increases in testosterone suggests that androstenediol is, in </div>
<div id="t1n_4" class="t s3_4">fact, preferentially converted to androstenedione rather than </div>
<div id="t1o_4" class="t s3_4">testosterone (Earnest et al., 2000). Possible mechanisms for </div>
<div id="t1p_4" class="t s3_4">this preference involve competitive enzyme binding reac-</div>
<div id="t1q_4" class="t s3_4">tions of 17Î²-hydroxysteroid dehydrogenase or feedback </div>
<div id="t1r_4" class="t s5_4">Table 1.</div>
<div id="t1s_4" class="t s6_4">The primary roles and side effects of dietary testosterone adjuncts.</div>
<div id="t1t_4" class="t s6_4">Supplement</div>
<div id="t1u_4" class="t s6_4">Main effects</div>
<div id="t1v_4" class="t s6_4">Side effects</div>
<div id="t1w_4" class="t s6_4">Androstenedione</div>
<div id="t1x_4" class="t s6_4">Increased androstenedione</div>
<div id="t1y_4" class="t s6_4">Decreased HDL-C, LDL/HDL/apoA/apoB ratio</div>
<div id="t1z_4" class="t s6_4">Variable testosterone response</div>
<div id="t20_4" class="t s6_4">Case report: impotence, oligospermia</div>
<div id="t21_4" class="t s6_4">Increased estrone, estradiol</div>
<div id="t22_4" class="t s6_4">Estrogen-mediated changes in lipid profile, fat mass, </div>
<div id="t23_4" class="t s6_4">prostate cancer risk, gynecomastia</div>
<div id="t24_4" class="t s6_4">Decreased LH</div>
<div id="t25_4" class="t s6_4">No change in lean body mass, fat mass</div>
<div id="t26_4" class="t s6_4">Androstenediol</div>
<div id="t27_4" class="t s6_4">Increased androstenediol, androstenedione</div>
<div id="t28_4" class="t s6_4">Decreased HDL-C, LDL/HDL/apoA/apoB ratio</div>
<div id="t29_4" class="t s6_4">No increase in testosterone</div>
<div id="t2a_4" class="t s6_4">Estrogen-mediated changes in lipid profile, fat mass, </div>
<div id="t2b_4" class="t s6_4">prostate cancer risk, gynecomastia</div>
<div id="t2c_4" class="t s6_4">Increased estrone, estradiol</div>
<div id="t2d_4" class="t s6_4">DHEA</div>
<div id="t2e_4" class="t s6_4">Increased DHEA, androstenedione</div>
<div id="t2f_4" class="t s6_4">No adverse effects reported due specifically to </div>
<div id="t2g_4" class="t s6_4">DHEA</div>
<div id="t2h_4" class="t s6_4">No changes in total testosterone, DHT</div>
<div id="t2i_4" class="t s6_4">Estrogen-mediated changes in lipid profile, fat mass, </div>
<div id="t2j_4" class="t s6_4">prostate cancer risk, gynecomastia</div>
<div id="t2k_4" class="t s6_4">Increased estrone, estradiol</div>
<div id="t2l_4" class="t s6_4">No effect on bone mineral density, fat mass, IIEF </div>
<div id="t2m_4" class="t s6_4">score</div>
<div id="t2n_4" class="t s7_4">Note</div>
<div id="t2o_4" class="t s8_4">. DHEA = dehydroepiandrosterone; DHT = dihydrotestosterone; HDL = high-density lipoprotein; IIEF = international index of erectile </div>
<div id="t2p_4" class="t s8_4">function; LH = leutinizing hormone; LDL = low-density lipoprotein.</div>
<div id="t2q_4" class="t s9_4">at UCSF LIBRARY &amp; CKM on February 4, 2016</div>
<div id="t2r_4" class="t s10_4">jmh.sagepub.com</div>
<div id="t2s_4" class="t s9_4">Downloaded from </div>

<form>
<input type="button"  tabindex="1"  id="form4_1" name="104 0 R"  pdfFieldName="104 0 R" onclick="window.open('http://jmh.sagepub.com/','_blank');" style="cursor:pointer;" title="http://jmh.sagepub.com/" />

</form>
<div id="pg4Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg4"><object width="893" height="1196" data="4/4.svg" type="image/svg+xml" id="pdf4" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 101;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_4");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
